Zai Lab ZLAB
NASDAQ ZLAB
$26.12 -0.88 (-3.26%)
As of: Sep 4, 2026 · 1:34 PM EDT

Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026)

Zai Lab (ZLAB) posted Non-Current Deffered Revenue of $28.6 million for Q1 2026, up 4.73% sequentially from $27.3 million in Q4 2025, and down 4.98% YoY from $30.1 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends

Zai Lab has reported Non-Current Deffered Revenue for 8 years, with the latest figure at $28.6 million in Q1 2026.

  • Quarterly Non-Current Deffered Revenue fell 4.98% year-over-year to $28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.6 million (down 4.98% YoY) and the FY2025 annual result came in at $27.3 million, down 13.04% from the prior year.
  • Non-Current Deffered Revenue advanced to $28.6 million in Q1 2026 per ZLAB's latest filing, from $27.3 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $31.4 million in Q4 2024 and troughed at $21.4 million in Q4 2022.
  • A 5-year average of $27.3 million and a median of $27.9 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue fell 22.29% in 2022, then jumped 34.54% in 2023.
  • Over 5 years, Non-Current Deffered Revenue stood at $21.4 million in 2022, then surged by 34.54% to $28.7 million in 2023, then climbed by 9.38% to $31.4 million in 2024, then dropped by 13.04% to $27.3 million in 2025, then increased by 4.73% to $28.6 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $28.6 million, $27.3 million, and $28.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Zai Lab 2.92 Bn 2.21 Bn 58.15 Mn 27.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.50 Mn
Mar 31, 2026 28.63 Mn
Dec 31, 2025 27.33 Mn
Sep 30, 2025 28.06 Mn
Jun 30, 2025 29.23 Mn
Mar 31, 2025 30.13 Mn
Dec 31, 2024 31.43 Mn
Sep 30, 2024 24.92 Mn
Jun 30, 2024 25.34 Mn
Mar 31, 2024 26.30 Mn
Dec 31, 2023 28.74 Mn
Sep 30, 2023 27.69 Mn
Jun 30, 2023 28.63 Mn
Mar 31, 2023 30.97 Mn
Dec 31, 2022 21.36 Mn
Sep 30, 2022 23.21 Mn
Jun 30, 2022 24.78 Mn
Dec 31, 2021 27.49 Mn
Dec 31, 2017 2.39 Mn
Dec 31, 2016 778,434.00